Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Lupus & Connective Tissue Diseases Lupus & Connective Tissue Diseases for November/December 2020 High-need, high-cost lupus patients described for first time, Slow taper off antimalarial is best to avoid lupus flare during remission, Sjögren’s symptom clusters may identify treatment options, Transcutaneous VNS on the ear shows positive effects in lupus pilot trial, More must reads Lupus & Connective Tissue Diseases for September/October 2020 ASSET extension supports abatacept as treatment for diffuse cutaneous systemic sclerosis, Novel study explores link between primary immunodeficiencies, rheumatic diseases, New lupus classification criteria perform well in children, young adults, Late-onset neutropenia more common than expected in patients on rituximab, Phone outreach intervention feasible to reduce SLE readmissions, More must readsLupus & Connective Tissue Diseases for July/August 2020 Researchers home in on optimal biopsy length for giant cell arteritis, Age, smoking among leading cancer risk factors for SLE patients, Cachexia affects more than half of lupus patients, Updated EULAR/ACR criteria identify more lupus patients, Inhaled treprostinil improves walk distance in patients with ILD-associated pulmonary hypertension, More must readsLupus & Connective Tissue Diseases for May/June 2020 First validated classification criteria for discoid lupus erythematosus unveiled, Belimumab safely improved renal function in lupus nephritis patients, Age leads COVID-19 hospitalization risk factors in RMDs, Avacopan notches a win in ANCA-associated vasculitis, Study tests a simpler low disease activity measure for lupus, More must readsLupus & Connective Tissue Diseases for March/April 2020 Dermatomyositis without dermatitis correlates with autoantibodies, U.S. prevalence of antinuclear antibodies has steadily risen, study finds, History of smoking gives higher risk for ANCA-associated vasculitis, With mild or stable lupus, few patients flare during, after pregnancy, Leflunomide-hydroxychloroquine combination for Sjögren’s shows potential, More must readsPages1 2 3 4 5 6 7 last »
